Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Scynexis Inc

NASDAQ: SCYX · Life Sciences · 3 alerts · CIK 1178253

Share price
$2.91Close, Nov 16
Market cap
$29M
Shares outstanding
9.95MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Scynexis Inc filings on SEC EDGAR ↗

8:02 AM ET 10-Q
Financial Results

Scynexis Q3 2026 Results: Net Loss of $8.46M, Loss Narrows

SCYNEXIS reported a net loss of $8.5 million for Q3 2026, with research and development expenses increasing to $6.2 million as the company advances its SCY-770 and SCY-247 programs. The company's liquidity was significantly bolstered by a $40.0 million private placement in March 2026 and a new BARDA contract awarded in September 2026 providing up to $213.9 million in potential non-dilutive funding.

Key figure
Net loss $8.46M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.